Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Recruiting · NCT06895499 · Registry updated 2026-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-07 | NCT06895499 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dermatology Hospital affiliated to Shandong First Medical University | 2 |
| Shanghai Huaota Biopharmaceutical Co., Ltd. | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dermatology Hospital affiliated to Shandong First Medical University | Jinan | China | 1 |